[1]
Wiastri, N.N.Y. et al. 2026. Janus Kinase Inhibitors Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis: A Systematic Review. Indonesian Journal of Global Health Research. 8, 5 (Sep. 2026), 1005–1014. DOI:https://doi.org/10.37287/ijghr.v8i5.2317.